Marginal structural models and other analyses allow multiple estimates of treatment effects in randomized clinical trials: Meta-epidemiological analysis-Reference-Cited by-同舟云学术

Marginal structural models and other analyses allow multiple estimates of treatment effects in randomized clinical trials: Meta-epidemiological analysis

Published:2019-03 Issue: Volume:107 Page:12-26
ISSN:0895-4356
Container-title:Journal of Clinical Epidemiology
language:en
Short-container-title:Journal of Clinical Epidemiology

Author:

Ewald Hannah,Speich Benjamin,Ladanie Aviv^ORCID,Bucher Heiner C.,Ioannidis John P.A.,Hemkens Lars G.

Funder

Laura and John Arnold Foundation

University of Basel

Publisher

Elsevier BV

Subject

Epidemiology

Reference69 articles.

1. What is meant by intention to treat analysis? Survey of published randomised controlled trials;Hollis;BMJ,1999

2. Beyond the intention to treat in comparative effectiveness research;Hernán;Clin Trials,2012

3. Seven myths of randomisation in clinical trials;Senn;Stat Med,2013

4. A new ‘Mechanistic-Practical' Framework for designing and interpreting randomized trials;Karanicolas;J Clin Epidemiol,2009

5. Randomized controlled trials: often flawed, mostly useless, clearly indispensable: a commentary on Deaton and Cartwright;Ioannidis;Soc Sci Med,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MultiSCRIPT-Cycle 1—a pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in multiple sclerosis: a study protocol for a randomized clinical trial;Trials;2024-09-11

2. Meta-research on pragmatism of randomized trials: rationale and design of the PragMeta database;Trials;2023-06-30

3. Meta-research on pragmatism of randomized trials: rationale and design of the PragMeta database;2023-03-09

4. Nutzenbewertung digitaler Gesundheitsanwendungen – Herausforderungen und Möglichkeiten;Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz;2021-09-15

5. No inexplicable disagreements between real-world data–based nonrandomized controlled studies and randomized controlled trials were found;Journal of Clinical Epidemiology;2021-05